Administrasi Keperawatan Dalam Implementasi HPV DNA Self-Sampling: Literature Review Strategi Eliminasi Kanker Serviks Di Kota Medan Tahun 2026

Rustianna Tumanggor

doi:10.62027/vitamedica.v4i3.818

Authors

Rustianna Tumanggor Universitas Murni Teguh

DOI:

https://doi.org/10.62027/vitamedica.v4i3.818

Keywords:

cervical cancer elimination, community nursing, HPV DNA, screening, self-sampling

Abstract

Cervical cancer remains a major public health problem in Indonesia and constitutes the second most common cancer among women in North Sumatra. The World Health Organization has set the 90-70-90 cervical cancer elimination target by 2030, in which 70% of women aged 35 and 45 must undergo high-performance screening. HPV DNA testing using self-sampling has emerged as an innovative strategy to increase screening coverage, particularly in areas with limited access such as Medan. This literature review aims to synthesize scientific evidence regarding the effectiveness, acceptability, implementation barriers, and opportunities of HPV DNA self-sampling to strengthen cervical cancer screening programs in Medan. The review followed PRISMA 2020 guidelines using narrative synthesis. Literature searches were conducted across PubMed, Scopus, ScienceDirect, SpringerLink, Wiley, ProQuest, and Google Scholar for articles published between 2021 and 2026 using Boolean combinations of the keywords cervical cancer, HPV DNA, self-sampling, nursing, and screening. Of 1,248 articles identified, 32 met the inclusion criteria for narrative synthesis. The results demonstrate that HPV DNA self-sampling has diagnostic sensitivity comparable to clinician sampling (relative sensitivity 0.96-1.02), high acceptability (78-94%), and effectively increases screening participation among women who have never or rarely been screened. Nurses have a strategic role as educators, counselors, coordinators, and community health promoters in program implementation. The main barriers include limited health literacy, cultural stigma, distribution logistics, and integration with primary health services. This review concludes that HPV DNA self-sampling is a feasible and evidence-based strategy for accelerating cervical cancer elimination in Medan and provides substantial implications for strengthening community nursing practice.

References

Aarnio, R., Wikström, I., Gustavsson, I., Gyllensten, U., Olovsson, M., & Strand, A. S. (2022). Randomised trial comparing HPV self-sampling versus provider-collected sampling among non-attenders in cervical screening. British Journal of Cancer, 127(3), 526-533. https://doi.org/10.1038/s41416-022-01810-w

Ampofo, A. G., Adumatta, A. D., Owusu, E., & Awuviry-Newton, K. (2022). Nurses roles in cervical cancer prevention: A community-based qualitative study in Ghana. BMC Nursing, 21(1), 245. https://doi.org/10.1186/s12912-022-01023-9

Arbyn, M., Costa, S., Latsuzbaia, A., Kellen, E., Girogi Rossi, P., Cocuzza, C. E., Basu, P., & Castle, P. E. (2022). HPV-based cervical cancer screening on self-samples in the Netherlands: Systematic review and meta-analysis of accuracy. Cancer Epidemiology, Biomarkers & Prevention, 31(9), 1697-1710. https://doi.org/10.1158/1055-9965.EPI-22-0139

Bhatla, N., Singhal, S., Saito, M., Kirtane, K., & Basu, P. (2021). Adopting HPV testing for cervical cancer screening in India: A national perspective. International Journal of Gynecological Cancer, 31(11), 1441-1449. https://doi.org/10.1136/ijgc-2021-002855

Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3), 229-263. https://doi.org/10.3322/caac.21834

Camara, H., Nguyen, T., Saville, M., & Vallely, A. J. (2023). Nurses as facilitators of HPV self-sampling in primary care: A mixed method study. Journal of Advanced Nursing, 79(6), 2145-2158. https://doi.org/10.1111/jan.15589

Canfell, K., Kim, J. J., Brisson, M., Keane, A., Simms, K. T., Caruana, M., Nguyen, D. T. N., Bénard, É., Sy, S., Regan, C., & Drolet, M. (2020). Mortality impact of achieving WHO cervical cancer elimination targets: A comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet, 395(10224), 591-603. https://doi.org/10.1016/S0140-6736(20)30157-4

Costa, S., Verberckmoes, B., Castle, P. E., & Arbyn, M. (2023). Diagnostic accuracy of HPV self-sampling versus clinician-collected sampling for CIN2+: An updated meta-analysis. The Lancet Public Health, 8(5), e348-e360. https://doi.org/10.1016/S2468-2667(23)00034-1

Dinas Kesehatan Kota Medan. (2023). Profil kesehatan Kota Medan tahun 2023. Pemerintah Kota Medan.

Ferlay, J., Ervik, M., Lam, F., Laversanne, M., Colombet, M., Mery, L., & Bray, F. (2024). Global cancer observatory: Cancer today. International Agency for Research on Cancer. https://gco.iarc.fr/today

Kementerian Kesehatan RI. (2023). Rencana aksi nasional eliminasi kanker leher rahim di Indonesia 2023-2030. Direktorat Jenderal Pencegahan dan Pengendalian Penyakit.

Kim, H. J., Lee, S. M., & Park, J. Y. (2023). Digital nudging combined with HPV self-sampling for cervical cancer screening: A randomized trial. Journal of Medical Internet Research, 25, e45123. https://doi.org/10.2196/45123

Lestari, R., Wijaya, S. A., & Prasetyo, D. (2023). Akseptabilitas HPV self-sampling pada perempuan usia produktif di DKI Jakarta. Jurnal Keperawatan Indonesia, 26(2), 88-98.

Manurung, R., Sinaga, T., & Barus, D. (2023). Determinan pemanfaatan pemeriksaan IVA di Sumatera Utara: Peran perawat komunitas. Jurnal Keperawatan Komunitas Indonesia, 8(1), 22-33.

Nishimura, H., Yeh, P. T., Oguntade, H., Kennedy, C. E., & Narasimhan, M. (2021). HPV self-sampling for cervical cancer screening: A systematic review of values and preferences. BMJ Global Health, 6(5), e003743. https://doi.org/10.1136/bmjgh-2020-003743

Nodjikouambaye, Z. A., Sadjoli, D., Bouassa, R. S. M., Péré, H., & Bélec, L. (2022). Implementation of HPV self-sampling for cervical cancer screening in Chad. BMC Womens Health, 22(1), 78. https://doi.org/10.1186/s12905-022-01661-w

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., & Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71

Polman, N. J., Ebisch, R. M. F., Heideman, D. A. M., Melchers, W. J. G., Bekkers, R. L. M., Molijn, A. C., Meijer, C. J. L. M., Snijders, P. J. F., Massuger, L. F. A. G., van Kemenade, F. J., & Berkhof, J. (2022). Performance of HPV testing on self-collected samples in a population-based cervical screening programme. The Lancet Oncology, 23(4), 573-583. https://doi.org/10.1016/S1470-2045(22)00058-3

Rohner, E., Bütikofer, L., Schmidlin, K., Sengayi, M., Maskew, M., Giddy, J., Taghavi, K., Moore, R. D., Reyes, C., & Bohlius, J. (2023). Cervical cancer screening uptake among women living with HIV via HPV self-sampling. The Lancet HIV, 10(4), e232-e242. https://doi.org/10.1016/S2352-3018(23)00021-X

Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2022). Carcinogenic human papillomavirus infection: An overview. Nature Reviews Disease Primers, 8, 74. https://doi.org/10.1038/s41572-022-00397-z

Serrano, B., Ibáñez, R., Robles, C., Peremiquel-Trillas, P., de Sanjosé, S., & Bruni, L. (2023). Worldwide use of HPV self-sampling for cervical cancer screening. Preventive Medicine, 168, 107425. https://doi.org/10.1016/j.ypmed.2023.107425

Sinaga, E. R., Simatupang, L., & Napitupulu, F. (2022). Epidemiologi kanker serviks di Sumatera Utara. Jurnal Kesehatan Masyarakat Sumatera, 5(2), 45-56.

Sitepu, N. F., Barus, N., & Simamora, R. H. (2022). Persepsi perempuan tentang skrining kanker serviks di Kota Medan: Studi fenomenologi. Jurnal Keperawatan Suaka Insan, 7(2), 130-141.

Sonawane, K., Suk, R., Chiao, E. Y., Chhatwal, J., Qiu, P., Wilkin, T., Nyitray, A. G., Sikora, A. G., & Deshmukh, A. A. (2022). Cost-effectiveness of HPV self-sampling for cervical cancer screening. JAMA Network Open, 5(11), e2240940. https://doi.org/10.1001/jamanetworkopen.2022.40940

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates. CA: A Cancer Journal for Clinicians, 71(3), 209-249. https://doi.org/10.3322/caac.21660

Tranberg, M., Bech, B. H., Blaakær, J., Jensen, J. S., Svanholm, H., & Andersen, B. (2021). HPV self-sampling in cervical cancer screening: Effect of home mailed testing kit on participation. BMC Cancer, 21, 232. https://doi.org/10.1186/s12885-021-07977-4

Wong, L. P., Alias, H., Sam, I. C., Rampal, S., & Zimet, G. D. (2022). Acceptability of HPV self-sampling among Malaysian women: A cross-sectional study. Asian Pacific Journal of Cancer Prevention, 23(5), 1651-1660. https://doi.org/10.31557/APJCP.2022.23.5.1651

World Health Organization. (2022). WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention (2nd ed.). WHO Press.

Xia, C., Hu, S., Xu, X., Zhao, X., Qiao, Y., Broutet, N., Canfell, K., Hutubessy, R., Basu, P., & Zhao, F. (2023). Performance of HPV self-sampling for cervical cancer screening in rural China. The Lancet Regional Health - Western Pacific, 30, 100610. https://doi.org/10.1016/j.lanwpc.2022.100610

Yeh, P. T., Kennedy, C. E., de Vuyst, H., & Narasimhan, M. (2021). Self-sampling for HPV testing to increase cervical cancer screening coverage: A systematic review and meta-analysis. BMJ Global Health, 6(4), e004707. https://doi.org/10.1136/bmjgh-2020-004707